MYLAN PHARMACEUTICALS PRIVATE

Company snapshot

MYLAN PHARMACEUTICALS PRIVATE LIMITED is a pharmaceuticals company based out of One India Bulls Centre, Tower 2-B, Mumbai, Maharashtra, India.

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for MYLAN PHARMACEUTICALS PRIVATE. Not investment advice.

• What is MYLAN PHARMACEUTICALS PRIVATE?

  Mylan IRE Healthcare is a pharma organization headquartered in GB. Primary therapeutic focus areas include Breast Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sourc

• Is MYLAN PHARMACEUTICALS PRIVATE publicly traded?

  MYLAN PHARMACEUTICALS PRIVATE appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does MYLAN PHARMACEUTICALS PRIVATE develop or market?

  We link 1 drug profile(s) where MYLAN PHARMACEUTICALS PRIVATE is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/mylan-ire-healthcare-limited#company-drugs.

• What are the latest developments for MYLAN PHARMACEUTICALS PRIVATE?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does MYLAN PHARMACEUTICALS PRIVATE focus on?

  MYLAN PHARMACEUTICALS PRIVATE focuses on Breast Cancer based on our analysis of their pipeline programs and drug development activities.